Bio-Rad Laboratories Basic EPS 2010-2025 | BIO
Bio-Rad Laboratories annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Bio-Rad Laboratories basic eps for the quarter ending March 31, 2025 was $2.29, a 82.99% decline year-over-year.
- Bio-Rad Laboratories basic eps for the twelve months ending March 31, 2025 was $-76.53, a 615.9% increase year-over-year.
- Bio-Rad Laboratories annual basic eps for 2024 was $-0.065B, a 199.54% increase from 2023.
- Bio-Rad Laboratories annual basic eps for 2023 was $-0.022B, a 82.08% decline from 2022.
- Bio-Rad Laboratories annual basic eps for 2022 was $-0.122B, a 185.4% decline from 2021.
| Bio-Rad Laboratories Annual Basic EPS | |
|---|---|
| 2024 | $-65.36 |
| 2023 | $-21.82 |
| 2022 | $-121.79 |
| 2021 | $142.61 |
| 2020 | $128.13 |
| 2019 | $58.93 |
| 2018 | $12.25 |
| 2017 | $4.12 |
| 2016 | $0.88 |
| 2015 | $3.74 |
| 2014 | $3.08 |
| 2013 | $2.72 |
| 2012 | $5.85 |
| 2011 | $6.39 |
| 2010 | $6.70 |
| 2009 | $5.28 |
| Bio-Rad Laboratories Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $2.29 |
| 2024-12-31 | $-25.93 |
| 2024-09-30 | $23.37 |
| 2024-06-30 | $-76.26 |
| 2024-03-31 | $13.46 |
| 2023-12-31 | $11.79 |
| 2023-09-30 | $3.65 |
| 2023-06-30 | $-39.59 |
| 2023-03-31 | $2.33 |
| 2022-12-31 | $27.24 |
| 2022-09-30 | $-5.48 |
| 2022-06-30 | $-31.05 |
| 2022-03-31 | $-112.50 |
| 2021-12-31 | $-52.62 |
| 2021-09-30 | $131.75 |
| 2021-06-30 | $30.71 |
| 2021-03-31 | $32.77 |
| 2020-12-31 | $28.33 |
| 2020-09-30 | $44.24 |
| 2020-06-30 | $32.59 |
| 2020-03-31 | $22.97 |
| 2019-12-31 | $18.50 |
| 2019-09-30 | $-8.68 |
| 2019-06-30 | $20.08 |
| 2019-03-31 | $29.03 |
| 2018-12-31 | $-27.81 |
| 2018-09-30 | $9.02 |
| 2018-06-30 | $8.99 |
| 2018-03-31 | $22.05 |
| 2017-12-31 | $2.79 |
| 2017-09-30 | $0.74 |
| 2017-06-30 | $0.17 |
| 2017-03-31 | $0.42 |
| 2016-12-31 | $-0.78 |
| 2016-09-30 | $0.63 |
| 2016-06-30 | $0.61 |
| 2016-03-31 | $0.42 |
| 2015-12-31 | $1.56 |
| 2015-09-30 | $0.59 |
| 2015-06-30 | $0.98 |
| 2015-03-31 | $0.61 |
| 2014-12-31 | $1.35 |
| 2014-09-30 | $0.40 |
| 2014-06-30 | $1.10 |
| 2014-03-31 | $0.23 |
| 2013-12-31 | $1.05 |
| 2013-09-30 | $-0.25 |
| 2013-06-30 | $1.21 |
| 2013-03-31 | $0.71 |
| 2012-12-31 | $1.53 |
| 2012-09-30 | $1.51 |
| 2012-06-30 | $1.71 |
| 2012-03-31 | $1.10 |
| 2011-12-31 | $2.15 |
| 2011-09-30 | $1.63 |
| 2011-06-30 | $1.43 |
| 2011-03-31 | $1.18 |
| 2010-12-31 | $2.44 |
| 2010-09-30 | $1.62 |
| 2010-06-30 | $1.37 |
| 2010-03-31 | $1.27 |
| 2009-12-31 | $1.38 |
| 2009-09-30 | $1.40 |
| 2009-06-30 | $1.39 |
| 2009-03-31 | $1.11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.639B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |